Gastrointestinal events and association with initiation of treatment for osteoporosis

References

• WrightNCLookerACSaagKGThe recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spineJ Bone Miner Res201429112520252624771492
   PubMed Web of Science ®Google Scholar
• BurgeRDawson-HughesBSolomonDHWongJBKingATostesonAIncidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025J Bone Miner Res200722346547517144789
   PubMed Web of Science ®Google Scholar
• Dawson-HughesBLookerACTostesonANJohanssonHKanisJAMeltonLJ3rdThe potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008Osteoporos Int201223381182021717247
   PubMed Web of Science ®Google Scholar
• WattsNBBilezikianJPCamachoPMAmerican Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosisEndocr Pract201016Suppl 313721224201
   PubMedGoogle Scholar
• GugginaPFlahiveJHoovenFHCharacteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohortBone201251697598022964142
   PubMed Web of Science ®Google Scholar
• AscheCNelsonRMcAdam-MarxCJhaveriMYeXPredictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USAOsteoporos Int20102181427143619798459
   PubMed Web of Science ®Google Scholar
• SirisESModiATangJGandhiSSenSSubstantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysisCurr Med Res Opin201430112313024102262
   PubMed Web of Science ®Google Scholar
• BrennanRMWactawski-WendeJCrespoCJDmochowskiJFactors associated with treatment initiation after osteoporosis screeningAm J Epidemiol2004160547548315321845
   PubMed Web of Science ®Google Scholar
• ColeRPPalushockSHaboubiAOsteoporosis management: physicians’ recommendations and womens’ compliance following osteoporosis testingWomen Health199929110111510427644
   PubMed Web of Science ®Google Scholar
• YoodRAMazorKMAndradeSEEmaniSChanWKahlerKHPatient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefsJ Gen Intern Med200823111815182118787907
   PubMed Web of Science ®Google Scholar
• KamnevaONyeAMHamrickIReasons for bisphosphonate exclusion in patients treated for osteoporosisConsult Pharm201126532533121733813
   PubMedGoogle Scholar
• BlumentalsWAHarrisSTColeREHuangLSilvermanSLRisk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronateAnn Pharmacother200943457758519318598
   PubMed Web of Science ®Google Scholar
• EttingerJPressmanAScheinJChanJSilverPConnollyNAlendronate use among 812 women: prevalence, complaints, noncompliance with patient instructionsJ Managed Care Pharm1998488492
   Google Scholar
• HamiltonBMcCoyKTaggartHTolerability and compliance with risedronate in clinical practiceOsteoporos Int200314325926212730745
   PubMed Web of Science ®Google Scholar
• VestergaardPSchwartzKPinholtEMRejnmarkLMosekildeLGastric and esophagus events before and during treatment of osteoporosisCalcif Tissue Int201086211011519957165
   PubMed Web of Science ®Google Scholar
• DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
   PubMed Web of Science ®Google Scholar
• BlockAESolomonDHCadaretteSMMogunHChoudhryNKPatient and physician predictors of post-fracture osteoporosis managementJ Gen Intern Med20082391447145118584260
   PubMed Web of Science ®Google Scholar
• FosterSAFoleyKAMeadowsESCharacteristics of patients initiating raloxifene compared to those initiating bisphosphonatesBMC Womens Health200882419105828
   PubMedGoogle Scholar
• WooCGaoGWadeSHochbergMCGastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US studyCurr Med Res Opin20102641003100920201623
   PubMed Web of Science ®Google Scholar
• PressmanAForsythBEttingerBTostesonANInitiation of osteoporosis treatment after bone mineral density testingOsteoporos Int200112533734211444079
   PubMed Web of Science ®Google Scholar
• GillespieCDHurvitzKACenters for Disease Control and PreventionPrevalence of hypertension and controlled hypertension – United States, 2007–2010MMWR Surveill Summ201362Suppl 314414824264505
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Health Interview StatisticsCrude and age-adjusted percentage of civilian, noninstitutionalized adults with diagnosed diabetes, United States, 1980–2011 Available from: http://www.cdc.gov/diabetes/statistics/prev/national/figageadult.htmAccessed September 22, 2014
   Google Scholar
• NicodemusKKFolsomARIowa Women’s Health StudyType 1 and type 2 diabetes and incident hip fractures in postmenopausal womenDiabetes Care20012471192119711423501
   PubMed Web of Science ®Google Scholar
• SchwartzAVSellmeyerDEEnsrudKEOlder women with diabetes have an increased risk of fracture: a prospective studyJ Clin Endocrinol Metab2001861323811231974
   PubMed Web of Science ®Google Scholar
• TaylorBCSchreinerPJStoneKLLong-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fracturesJ Am Geriatr Soc20045291479148615341549
   PubMed Web of Science ®Google Scholar
• HiligsmannMDellaertBGDirksenCDPatients’ preferences for osteoporosis drug treatment: a discrete-choice experimentArthritis Res Ther2014161R3624479410
   PubMed Web of Science ®Google Scholar
• ReynoldsKViswanathanHNO’MalleyCDPsychometric properties of the osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonatesAnn Pharmacother201246565967022510666
   PubMed Web of Science ®Google Scholar
• LoJCPressmanAROmarMAEttingerBPersistence with weekly alendronate therapy among postmenopausal womenOsteoporos Int200617692292816609824
   PubMed Web of Science ®Google Scholar
• YunHCurtisJRGuoLPatterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiariesBMC Musculoskelet Disord20141511224684864
   PubMed Web of Science ®Google Scholar
• No authors listedManagement of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause SocietyMenopause2010171255420061894
   PubMed Web of Science ®Google Scholar
• GoldDTBonnickSLAmonkarMMKamelHKAgarwalSZaidiMDescriptive analysis of concomitant prescription medication patterns from 1999 to 2004 among US women receiving daily or weekly oral bisphosphonate therapyGend Med20085437438419108810
   PubMedGoogle Scholar